The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein microarrays, enabling researchers to delve deeper into the complexities of the proteome. Moreover, the escalating demand for targeted and precision medicine, coupled with the increasing prevalence of chronic diseases, further propels the adoption of proteomic solutions.
Allied Market Research published a report, titled, “Proteomics Market by Component (Reagents, Instruments, and Services), and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “proteomics market” was valued at $32.8 billion in 2023, and is estimated to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035.
Key Takeaways
- On the basis of component, the reagent segment dominated the market in terms of revenue in 2023.
- On the basis of application, the drug discovery segment dominated the market in terms of revenue in 2023.
- On the basis of region, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Request Sample of the Report on- https://www.alliedmarketresearch.com/request-sample/1677
Proteomics focuses on the comprehensive analysis of proteins within a biological system. Unlike genomics, which examines the entirety of an organism’s genetic material, proteomics delves into the intricate world of proteins, the functional workhorses of cells. It involves the large-scale study of the structure, function, and interactions of proteins, aiming to understand their roles in biological processes and disease states. Proteomics employs various techniques, including mass spectrometry, protein microarrays, and bioinformatics tools, to identify, quantify, and characterize proteins present in cells, tissues, or organisms.
2025 Recession Impact Analysis
- The global recession had a significant impact on the proteomics market.
- The economic uncertainty has negatively impacted the research and development activities in the proteomics market.
- However, the proteomics market is expected to recover owing to high adoption of proteomics for the treatment of chronic diseases and drug discovery and development procedures.
Segments Overview
The reagents segment to maintain its leadership status throughout the forecast period
By component, the reagent segment held the highest market share in 2023 and is expected to dominate during the forecast period, accounting for more than three-fourths of the proteomics market revenue, owing to high use of reagents for every laboratory research work of proteomics.
The drug discovery segment to maintain its leadership status throughout the forecast period
By application, the drug discovery segment held the highest market share in 2023, accounting for more than half of the proteomics market revenue. This is attributed to proteomics being widely adopted to evaluate the drug candidate in various parameters such as safety profile, efficacy, and toxicology during the preclinical trials.
North America to maintain its leadership status throughout the forecast period.
By region, North America held the highest market share in 2023, accounting for more than two-fifths of the proteomics market revenue. This is attributed to well-established healthcare infrastructure and rise in the prevalence of chronic diseases. However, Asia-Pacific is expected to register a noteworthy CAGR during the forecast period, owing to developing pharmaceutical industries in the region.
Leading Market Players: –
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc
- Danaher Corporation
- Bruker Corporation
- Waters Corporation
- Perkin Elmer Inc
- Horiba Ltd.
- Merck KGaA
- Agilent Technologies Inc
- Li-Cor Inc
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2023 to 2035 to identify the prevailing proteomics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.
You may Also Like
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
